米非司酮联合生化汤治疗外加手术治疗胎盘粘连及植入-国际中医药研究-CSCIED科技核心评价数据库-手机版

米非司酮联合生化汤治疗外加手术治疗胎盘粘连及植入

Mifepristone combined with Shenghua decoction in the treatment of placental adhesion and implantationwith surgery

ES评分 0 浏览量：856 下载量：0

DOI	10.12208/j.ircm.20220042
刊名	国际中医药研究 International Research in Chinese Medicine
年，卷(期)	2022, 2(2)
作者	曹晶*,
作者单位	武汉市蔡甸区妇幼保健院湖北武汉 ;
摘要	探究在胎盘粘连及植入治疗当中应用米非司酮联合生化汤外加手术治疗的最终疗效。方法在2021年12月~2022年6月期间，邀请50名胎盘粘连及植入患者参与本次实验，对所有患者进行胎盘粘连及植入的相应手术，并且为患者提供米非司酮和生化汤的联合治疗，通过观察第一疗程和第二疗程当中患者阴道出血情况，胎盘完全排除比率，子宫恢复良好情况等指标对本次实验应用的方法进行探讨。结果治疗的第一疗程完成后，所有患者阴道出血情况均已停止，胎盘完全排除率占80%，60%已经恢复子宫良好。治疗的第二疗程完成后，患者的胎盘完全排除率上升到100%，子宫恢复良好情况上升为100%。结论本次实验证明了米非司酮联合生化汤外加手术治疗胎盘粘连及植入具有明显的疗效。
Abstract	Objective To explore the final effect of mifepristone combined with Shenghua decoction plus surgery in the treatment of placental adhesion and implantation. Methods During the period from December 2021 to June 2022, 50 patients with placental adhesion and implantation were invited to participate in this experiment. All patients were subjected to the corresponding operations of placental adhesion and implantation, and the patients were provided with mifepristone and biochemical For the combined treatment of decoction, the method applied in this experiment was discussed by observing the vaginal bleeding, the rate of complete exclusion of placenta, and the recovery of the uterus in the first and second courses of treatment. Results After the completion of the first course of treatment, vaginal bleeding in all patients had stopped, the placenta was completely excluded in 80%, and 60% had recovered to a good uterus. After the second course of treatment was completed, the patients complete placental exclusion rate rose to 100%, and the uterus recovered well to 100%. Conclusion This experiment proves that mifepristone combined with Shenghua decoction plus surgery has obvious curative effect in the treatment of placental adhesion and implantation.
关键词	米非司酮；生化汤；手术；胎盘粘连及植入
KeyWord	Mifepristone; Shenghua decoction; Surgery; Placental adhesion and implantation
基金项目
页码	97-99

参考文献
相关文献

[1] 李书平. 米非司酮治疗胎盘植入和胎盘粘连的效果研究[J]. 中国继续医学教育,2021,13(26):153-156.

[2] 陶然. 米非司酮治疗部分胎盘植入和胎盘粘连的临床观察[J]. 中国医药指南,2021,19(2):47-48.

[3] 王莉娜,张宁. 米非司酮治疗胎盘植入和胎盘粘连的效果分析[J]. 药店周刊,2021,30(30):21,25.

[4] 王媛媛,武建利,王云玲,等. 胎盘植入的MRI表现及其对分型的诊断意义分析[J]. 中国CT和MRI杂志,2022,20(6):113-115.

[5] 薛晶晶,王莉,崔静静,等. 宫颈受累的超声征象对胎盘植入性疾病临床分级诊断及不良妊娠结局的预测价值[J]. 中华超声影像学杂志,2022,31(2):135-139.

[6] 宋学薇,孙佳,刘亚梅,等. 胎盘粘连植入组织和人胎盘滋养层细胞中VCAM-1的表达及其与侵入性胎盘疾病的相关性[J]. 标记免疫分析与临床,2020,27(2):299-304,314.

[7] 董芳. 解析米非司酮在胎盘粘连或植入治疗中的应用[J]. 母婴世界,2020(28):108.

[8] 邱光银. 胎盘植入的临床分析[J]. 特别健康,2019(20):127-128.

[9] 刘莎莎. 米非司酮在胎盘粘连及胎盘植入患者治疗中的应用价值[J]. 家庭医药,2019(3):112-113.

[10] 冯莉,谢芳芳.甲氨蝶呤联合米非司酮治疗异位妊娠的效果[J].中国继续医学教育.2020,(29).120~122.

引用本文

曹晶*. 米非司酮联合生化汤治疗外加手术治疗胎盘粘连及植入 [J]. 国际中医药研究. 2022; 2; (2). 97 - 99.

文献评论

相关学者

相关机构